Core Viewpoint - MicroTech Medical-B (02235) has received approval for its LinX continuous glucose monitoring system in Brazil, which is applicable for both adults and children, significantly enhancing the company's market presence in Latin America [1] Group 1: Product Approval - The LinX continuous glucose monitoring system has been approved for sale in Brazil, marking a key milestone for the company [1] - This approval is expected to strengthen the company's market positioning in Latin America [1] Group 2: Business Expansion - The approval lays a solid foundation for the company's international business expansion and revenue growth [1] - The company will continue to focus on the global development of diabetes monitoring, treatment, and management [1] Group 3: Innovation Focus - The company aims to drive ongoing technological and product innovation in the relevant fields [1]
微泰医疗-B(02235)LinX持续葡萄糖监测系统在巴西获批上市